LRP5 and exudative vitreoretinopathy: Human patients with loss-of-function variants in LRP5 can also develop familial exudative vitreoretinopathy (FEVR), a disease characterized by a paucity of blood vessels at the retinal periphery and hemorrhages of other regional blood vessels (Le et al., 2023).